Share of people with HIV who receive antiretroviral therapy in Gambia
Gambia: Share of people with HIV who receive antiretroviral therapy was 44.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Gambia, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
In 2024, share of people with hiv who receive antiretroviral therapy in Gambia stood at 44.0%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 10.0% on the previous year and up 158.8% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Gambia peaked at 44.0% in 2024 and was at its lowest, 0.0%, in 2000.
Gambia ranks 130th of 143 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Gambia, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 2.0% | — |
| 2006 | 2.0% | +0.0% |
| 2007 | 2.0% | +0.0% |
| 2008 | 4.0% | +100.0% |
| 2009 | 5.0% | +25.0% |
| 2010 | 9.0% | +80.0% |
| 2011 | 13.0% | +44.4% |
| 2012 | 16.0% | +23.1% |
| 2013 | 16.0% | +0.0% |
| 2014 | 17.0% | +6.2% |
| 2015 | 19.0% | +11.8% |
| 2016 | 23.0% | +21.1% |
| 2017 | 26.0% | +13.0% |
| 2018 | 29.0% | +11.5% |
| 2019 | 31.0% | +6.9% |
| 2020 | 32.0% | +3.2% |
| 2021 | 33.0% | +3.1% |
| 2022 | 38.0% | +15.2% |
| 2023 | 40.0% | +5.3% |
| 2024 | 44.0% | +10.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.5% | 0.0% | 5.0% | 10 |
| 2010s | 19.9% | 9.0% | 31.0% | 10 |
| 2020s | 37.4% | 32.0% | 44.0% | 5 |
Countries ranked near Gambia
More health data for Gambia
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,044 deaths per 1,000 people (2090)
- Number of infants who die before age 1 700 deaths (2100)
- Population ages 40-44, male, annual growth rate 5.26 % change on previous year (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per capita 0.022 units per person (2025)
- Population ages 45-49, female, annual growth rate 3.22 % change on previous year (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per capita 0.017 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Gambia?
- Share of people with hiv who receive antiretroviral therapy in Gambia was 44.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Gambia?
- The highest recorded value was 44.0% in 2024.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Gambia?
- The lowest recorded value was 0.0% in 2000.
- How does Gambia rank for share of people with hiv who receive antiretroviral therapy?
- Gambia ranks 130th out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Gambia?
- Over the last ten years it is up 158.8%. The long-run trend across the full record is volatile.
- Where does this Gambia data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.